Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Bücher
Zeitschriften
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
SLX-Digitalkonferenz: Zukunftswerkstatt 2024

Mehr Umsatz mit Top-Kontakten

Am 7. Mai erfahren Sie, wie Vertriebsteams Leadgenerierung, Leadnurturing und Leadstrategien effizient steuern können.
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
Antibacterials Kapitel lesen Erstes Kapitel lesen

2021 | OriginalPaper | Buchkapitel

5. Future Possibilities

verfasst von : John Bremner

Erschienen in: Multiple Action-Based Design Approaches to Antibacterials

Verlag: Springer Singapore

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

There are many possibilities for the future design of new multi-targeted antibacterials based on developing knowledge of synergistic combinations and new modes of action being discovered. This final chapter includes a comparative assessment of the combination, hybrid and prodrug approaches, together with a discussion of the potential for using new drug combinations, especially incorporating new modes of action, in new hybrid or prodrug designs. A concluding section covers some more general thoughts on the need to think well outside the square in the design and development of antibacterials to help in the fight against the ever increasing threat of resistance.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren
Vorheriges Kapitel Design Principles and Development of Prodrugs for Multiply Active Antibacterials
Literatur
Abdeen S, Salim N, Mammadova N et al. (2016) GroEL/ES inhibitors as potential antibiotics. Bioorg Med Chem Lett 26(13):3127–3134PubMedCrossRef
Abdeen S, Kunkle T, Salim N et al. (2018) Sulfonamido-2-arylbenzoxazole GroEL/ES inhibitors are potent antibacterials against methicillin-resistant Staphylococcus aureus (MRSA). J Med Chem 61(16):7345–7357PubMedPubMedCentralCrossRef
Åberg V, Almqvist F (2007) Pilicides-small molecules targeting bacterial virulence. Org Biomol Chem 5 (12):1827–1834PubMedCrossRef
Ahmad I, Ahmad S, Rumbaugh KP (eds) (2020) Antibacterial drug discovery to combat MDR: Natural compounds, nanotechnology and novel synthetic sources. Springer Verlag, Singapore
Alexander MK, Miu A, Oh A et al. (2018) Disrupting Gram-negative bacterial outer membrane biosynthesis through inhibition of the lipopolysaccharide transporter MsbA. Antimicrob Agents Chemother 62 (11):e01142–01118PubMedPubMedCentralCrossRef
Alix J-H (2013) Targeting HSP70 to fight cancer and bad bugs: One and the same battle? In: Gualerzi CO, Brandi L, Fabbretti A et al. (eds) Antibiotics: Targets, mechanisms and resistance. Wiley-VCH Verlag GmbH, Weinheim, pp 525–538
Altieri AS, Kelman Z (2018) DNA sliding clamps as therapeutic targets. Front Microbiol 5: Article 87
Anju CP, Subhramanian S, Sizochenko N et al. (2019) Multiple e-Pharmacophore modeling to identify a single molecule that could target both streptomycin and paromomycin binding sites for 30S ribosomal subunit inhibition. J Biomol Struct Dyn 37 (6):1582–1596CrossRef
Arvanitis M, Glavis-Bloom J, Mylonakis E (2013) C. elegans for anti-infective discovery. Curr Opin Pharmacol 13 (5):769–774
Baell JB, Leaver DJ, Hermans SJ et al. (2018) Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. Nature 560:253–257PubMedCrossRef
Baell JB (2021) Personal accounts of Australian drug discovery at the public-private interface. Aust J Chem 74:16–27CrossRef
Begley DW, Fox D, 3rd, Jenner D et al. (2014) A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins. Antimicrob Agents Chemother 58 (3):1458–1467PubMedPubMedCentralCrossRef
Benkendorff K, Bremner JB, Davis AR (2000) Tyrian purple precursors in the egg masses of the Australian muricid, Dicathais orbita: A possible defensive role. J Chem Ecol 26(4):1037–1050CrossRef
Biswas NN, Iskander GM, Mielczarek M et al. (2018) Alkyne-substituted fimbrolide analogues as novel bacterial quorum-sensing inhibitors. Aust J Chem 71 (9):708–715CrossRef
Blount KF, Breaker RR (2006) Riboswitches as antibacterial drug targets. Nat Biotechnol 24 (12):1558–1564PubMedCrossRef
Boström J, Brown DG, Young RJ et al. (2018) Expanding the medicinal chemistry synthetic toolbox. Nat Rev Drug Discov 17:709–727PubMedCrossRef
Boyaci H, Chen J, Lilic M et al. (2018) Fidaxomicin jams Mycobacterium tuberculosis RNA polymerase motions needed for initiation via RbpA contacts. Elife 7:e34823PubMedPubMedCentralCrossRef
Branson TR, Turnbull WB (2013) Bacterial toxin inhibitors based on multivalent scaffolds. Chem Soc Rev 42 (11):4613–4622PubMedCrossRef
Brown DG, Boström J (2016) Analysis of past and present synthetic methodologies on medicinal chemistry: where have all the new reactions gone? J Med Chem 59 (10):4443–4458PubMedCrossRef
Buonanno F, Anesi A, Guella G et al. (2017) Blepharismins used for chemical defense in two ciliate species of the genus Blepharisma, B. stoltei and B. undulans (Ciliophora: Heterotrichida). Eur Zool J 84(1):402–409
Buroni S, Scoffone VC, Fumagalli M et al. (2018) Investigating the mechanism of action of diketopiperazines inhibitors of the Burkholderia cenocepacia quorum sensing synthase Cepl: A site-directed mutagenesis study. Front Pharmacol 9: Article 836
Calvert MB, Jumde VR, Titz A (2018) Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections. Beilstein J Org Chem 14:2607–2617PubMedPubMedCentralCrossRef
Carney DW, Schmitz KR, Truong JV et al. (2014) Restriction of the conformational dynamics of the cyclic acyldepsipeptide antibiotics improves their antibacterial activity. J Am Chem Soc 136:1922–1929PubMedPubMedCentralCrossRef
Chen H, Engkvist O (2019) Has drug design augmented by artificial intelligence become a reality? Trends Pharmacol Sci 40 (11):806–809
Chu J, Vila-Farres X, Inoyama D et al. (2016) Discovery of MRSA active antibiotics using primary sequence from the human microbiome. Nat Chem Biol 12 (12):1004–1006PubMedPubMedCentralCrossRef
Cockburn CL, Green RS, Damle SR et al. (2019) Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens. Life Sci Alliance 2 (2):e201800292PubMedPubMedCentralCrossRef
Cohen F, Aggen JB, Andrews LD et al. (2019) Optimization of LpxC inhibitors for antibacterial activity and cardiovascular safety. ChemMedChem 14:1560–1572PubMedCrossRef
Cully M (2018) Roche taps potential antibiotics mine with Warp Drive Bio. Nat Rev Drug Discov 17:8PubMedCrossRef
Culp EJ, Waglechner N, Wang W et al. (2020) Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling. Nature 578 (7796):582–587PubMedCrossRef
Duncan LF, Wang G, Ilyichova OV et al. (2019) The fragment-based development of a benzofuran hit as a new class of Escherichia coli DsbA inhibitors. Molecules 24 (20):3756
Elgart M, Soen Y (2018) Microbiome-germline interactions and their transgenerational implications. BioEssays 40 (4):1700018CrossRef
Elnaas AR, Grice D, Han J et al. (2020) Discovery of a natural product that binds to the Mycobacterium tuberculosis protein Rv1466 using native mass spectrometry. Molecules 25 (10):2384PubMedCentralCrossRef
Feigman MS, Kim S, Pidgeon SE et al. (2018) Synthetic immunotherapeutics against Gram-negative pathogens. Cell Chem Biol 25 (10):1185–1194.e1185PubMedPubMedCentralCrossRef
Fer MJ, Corre LL, Pietrancosta N et al. (2018) Bacterial transferase MraY, a source of inspiration towards new antibiotics. Curr Med Chem 25 (42):6013–6029PubMedCrossRef
Feringa BL (2017) The art of building small: From molecular switches to motors (Nobel Lecture). Angew Chem Int Ed 56 (37):11060–11078CrossRef
Fischer N, Neumann P, Konevega AL et al. (2015) Structure of the E. coli ribosome–EF-Tu complex at <3 Å resolution by Cs-corrected cryo-EM. Nature 520:567–570PubMedCrossRef
Frapwell CJ, Skipp PJ, Howlin RP et al. (2020) Antimicrobial activity of the quinoline derivative HT61 against Staphylococcus aureus biofilms. Antimicrob Agents Chemother 64 (5):e02073–02019PubMedPubMedCentralCrossRef
Geng J, Weishuo L, Zhang Y et al. (2019) Radical polymerization inside living cells. Nat Chem 11:578–586PubMedCrossRef
Gerry CJ and Schreiber SL (2020) Recent achievements and current trajectories of diversity-oriented synthesis. Curr Opin Chem Biol 56: 1–9PubMedCrossRef
Giddings L-A, Newman DJ (2015) Bioactive compounds from terrestrial extremophiles. Springer, Cham, Switzerland, pp 1–90
González A, Fillat MF, Lanas Á (2018) Transcriptional regulators: valuable targets for novel antibacterial strategies. Future Med Chem 10 (5):541–560PubMedCrossRef
Gopal P, Dick T (2020) Targeted protein degration in antibacterial drug discovery? Prog Biophys Mol Biol 152: 10–14PubMedCrossRef
Gu S, Cui D, Chen X et al. (2018) PROTACs: An emerging targeting technique for protein degradation in drug discovery. Bioessays 40 (4):e1700247PubMedCrossRef
Gunderson CW, Segall AM (2006) DNA repair, a novel antibacterial target: Holliday junction-trapping peptides induce DNA damage and chromosome segregation defects. Mol Microbiol 59 (4):1129–1148PubMedCrossRef
Haque S, Ahmad F, Dar SA et al. (2018) Developments in strategies for quorum sensing virulence factor inhibition to combat bacterial drug resistance. Microb Pathog 121:293–302PubMedCrossRef
Hart EM, Mitchell AM, Konovalova A et al. (2019) A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier. Proc Natl Acad Sci 116 (43):21748PubMedCrossRefPubMedCentral
Heras B, Scanlon MJ, Martin JL (2015) Targeting virulence not viability in the search for future antibacterials. Br J Clin Pharmacol 79 (2):208–215PubMedPubMedCentralCrossRef
Herzik MA, Jr. (2020) Cryo-electron microscopy reaches atomic resolution. Nature 587 (7832):39–40PubMedCrossRef
Ho H, Miu A, Alexander MK et al. (2018) Structural basis for dual-mode inhibition of the ABC transporter MsbA. Nature 557 (7704):196–201PubMedCrossRef
Hu LI, Lima BP, Wolfe AJ (2010a) Bacterial protein acetylation: the dawning of a new age. Mol Microbiol 77 (1):15–21
Hu Y, Shamaei-Tousi A, Liu Y et al. (2010b) A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: A novel topical antibiotic for staphylococcal infections. PLoS One 5 (7):e11818
Ikeya T, Hanashima T, Hosoya S et al. (2016) Improved in-cell structure determination of proteins at near-physiological concentration. Sci Rep 6 (1):38312PubMedPubMedCentralCrossRef
Jia X, Lynch A, Huang Y et al. (2019) Anthropogenic biases in chemical reaction data hinder exploratory inorganic synthesis. Nature 573 (7773):251–255PubMedCrossRef
Jacobsson S, Mason C, Khan N et al. (2019) In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment options for gonorrhoea? J Antimicrob Chemother 74: 1591–1594PubMedPubMedCentralCrossRef
Johnson EO, LaVerriere E, Office E et al. (2019) Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes. Nature 571 (7763):72–78
Koppermann S, Cui Z, Fischer PD et al. (2018) Insights into the target interaction of naturally occurring muraymycin nucleoside antibiotics. ChemMedChem 13 (8):779–784PubMedPubMedCentralCrossRef
Krajewski SS, Ignatov D, Johansson J (2017) Two are better than one: Dual targeting of riboswitches by metabolite analogs. Cell Chem Biol 24 (5):535–537PubMedCrossRef
Kroeck KG, Sacco MD, Smith EW et al. (2019) Discovery of dual-activity small-molecule ligands of Pseudomonas aeruginosa LpxA and LpxD using SPR and X-ray crystallography. Sci Rep 9 (1):15450
Leaver DJ, Dawson RM, White JM et al. (2011) Synthesis of 1,2,3-triazole linked galactopyranosides and evaluation of cholera toxin inhibition. Org Biomol Chem 9 (24):8465–8474PubMedCrossRef
Lebraud H, Wright DJ, Johnson CN et al. (2016) Protein degradation by in-cell self-assembly of proteolysis targeting chimeras. ACS Cent Sci 2 (12):927–934PubMedPubMedCentralCrossRef
Liu F, Ma S (2018) Recent process in the inhibitors of UDP-3-O-(R-3-hydroxyacyl)-N-acetylglucosamine deacetylase (LpxC) against Gram-negative bacteria. Mini Rev Med Chem 18 (4):310–323
Lobban CS, Hallam SJ, Mukherjee P et al. (2007) Photophysics and multifunctionality of hypericin-like pigments in heterotrich ciliates: A phylogenetic perspective. Photochem Photobiol 83:1074–1094PubMedCrossRef
Luechtefeld T, Marsh D, Rowlands C et al. (2018) Machine learning of toxicological big data enables read-across structure activity relationships (RASAR) outperforming animal test reproducibility. Toxicol Sci 165 (1):198–212PubMedPubMedCentralCrossRef
Lupoli TJ, Vaubourgeix J, Burns-Huang K et al. (2018) Targeting the proteostasis network for mycobacterial drug discovery. ACS Infect Dis 4:478–498PubMedPubMedCentralCrossRef
Luther A, Urfer M, Zahn M et al. (2019) Chimeric peptidomimetic antibiotics against Gram-negative bacteria. Nature 576 (7787):452–458PubMedCrossRef
Maeda T, García-Contreras R, Pu M et al. (2012) Quorum quenching quandary: resistance to antivirulence compounds. ISME J 6:493–501PubMedCrossRef
Mashalidis EH, Kaeser B, Terasawa Y et al. (2019) Chemical logic of MraY inhibition by antibacterial nucleoside natural products. Nat Commun 10 (1):2917PubMedPubMedCentralCrossRef
Megget K (2018) Novartis exit from antibiotics a setback for race against resistance. Chem World 15(9):48–49
Monserrat-Martinez A, Gambin Y, Sierecki E (2019) Thinking outside the bug: Molecular targets and strategies to overcome antibiotic resistance. Int J Mol Sci 20 (6):1255PubMedCentralCrossRef
Nickerson NN, Jao CC, Xu Y et al. (2018) A Novel inhibitor of the LolCDE ABC transporter essential for lipoprotein trafficking in Gram-negative bacteria. Antimicrob Agents Chemother 62 (4):e02151–02117PubMedPubMedCentralCrossRef
Nizalapur S, Kimyon Ö, Biswas NN et al. (2016) Design, synthesis and evaluation of N-aryl-glyoxamide derivatives as structurally novel bacterial quorum sensing inhibitors. Org Biomol Chem 14 (2):680–693
Nuti DE, Crump RB, Dwi Handayani F et al. (2011) Identification of circulating bacterial antigens by in vivo microbial antigen discovery. mBio 2 (4):e00136–11
Pant B, Kato Y, Kumagai T et al. (1997) Blepharismin produced by a protozoan Blepharisma functions as an antibiotic effective against methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett 155 (1):67–71PubMedCrossRef
Peeters SH, de Jonge MI (2018) For the greater good: Programmed cell death in bacterial communities. Microbiol Res 207:161–169PubMedCrossRef
Petrelli D, Buonanno F, Vitali LA et al. (2012). Antimicrobial activity of the protozoan toxin climacostol and its derivatives. Biologia 67:525–529CrossRef
Renaud J-P, Chari A, Ciferri C et al. (2018) Cryo-EM in drug discovery: achievements, limitations and prospects. Nat Rev Drug Discov 17 (7):471–492PubMedCrossRef
Rideout MC, Boldt JL, Vahi-Ferguson G et al. (2011) Potent antimicrobial small molecules screened as inhibitors of tyrosine recombinases and Holliday junction-resolving enzymes. Mol Divers 15 (4):989PubMedCrossRef
Robinson A, van Oijen AM (2013) Bacterial replication, transcription and translation: mechanistic insights from single-molecule biochemical studies. Nat Rev Microbiol 11 (5):303–315PubMedCrossRef
Robinson JA (2019) Folded synthetic peptides and other molecules targeting outer membrane protein complexes in Gram-negative bacteria. Front Chem 7: Article 45
Rodrigues T, Werner M, Roth J et al. (2018) Machine intelligence decrypts β-lapachone as an allosteric 5-lipoxygenase inhibitor. Chem Sci 9 (34):6899–6903PubMedPubMedCentralCrossRef
Sader HS, Dale GE, Rhomberg PR et al. (2018) Antimicrobial activity of murepavadin tested against clinical isolates of Pseudomonas aeruginosa from the United States, Europe, and China. Antimicrob Agents Chemother 62 (7):e00311–00318PubMedPubMedCentralCrossRef
Sakakibara D, Sasaki A, Ikeya T et al. (2009) Protein structure determination in living cells by in-cell NMR spectroscopy. Nature 458 (7234):102–105PubMedCrossRef
Scapin G, Potter CS, Carragher B (2018) Cryo-EM for small molecules discovery, design, understanding, and application. Cell Chem Biol 25 (11):1318–1325PubMedPubMedCentralCrossRef
Schaenzer AJ, Wlodarchak N, Drewry DH et al. (2017) A screen for kinase inhibitors identifies antimicrobial imidazopyridine aminofurazans as specific inhibitors of the Listeria monocytogenes PASTA kinase PrkA. J Biol Chem 292 (41):17037–17045
Schilling NA, Berscheid A, Schumacher J et al. (2019) Synthetic lugdunin analogues reveal essential structural motifs for antimicrobial action and proton translocation capability. Angew Chem Int Ed 58 (27):9234–9238CrossRef
Schütz C, Empting M (2018) Targeting the Pseudomonas quinolone signal quorum sensing system for the discovery of novel anti-infective pathoblockers. Beilstein J Org Chem 14:2627–2645PubMedPubMedCentralCrossRef
Segler MHS, Preuss M, Waller MP (2018) Planning chemical syntheses with deep neural networks and symbolic AI. Nature 555 (7698):604–610PubMedCrossRef
Shang Z, Winter JM, Kauffman CA et al. (2019) Salinipeptins: Integrated genomic and chemical approaches reveal unusual D-amino acid-containing ribosomally synthesized and post-translationally modified peptides (RiPPs) from a Great Salt Lake Streptomyces sp. ACS Chem Biol 14:415–425
Silver LL (2014) Antibacterials for any target. Nat Biotech 32 (11):1102–1104
Sittampalam GS, Rudnicki DD, Tagle DA et al. (2019) Mapping biologically active chemical space to accelerate drug discovery. Nat Rev Drug Discov 18 (2):83–84PubMedPubMedCentralCrossRef
Smith PA, Koehler MFT, Girgis HS et al. (2018) Optimized arylomycins are a new class of Gram-negative antibiotics. Nature 561 (7722):189–194PubMedCrossRef
Sousa MC (2019) New antibiotics target the outer membrane of bacteria. Nature 576 (7787):389–390PubMedCrossRef
Srinivas N, Jetter P, Ueberbacher BJ et al. (2010) Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327 (5968):1010–1013
Stevens M, Abdeen S, Salim N et al. (2019) HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules. Bioorg Med Chem Lett 29(9):1106–1112PubMedPubMedCentralCrossRef
Styles MJ, Blackwell HE (2018) Non-native autoinducer analogs capable of modulating the SdiA quorum sensing receptor in Salmonella enterica serovar Typhimurium. Beilstein J Org Chem 14:2651–2664PubMedPubMedCentralCrossRef
Su C-C, Morgan CE, Kambakam S et al. (2019) Cryo-electron microscopy structure of an Acinetobacter baumannii multidrug efflux pump. mBio 10 (4):e01295–01219
Tanaka T, Ikeya T, Kamoshida H et al. (2019) High-resolution protein 3D structure determination in living eukaryotic cells. Angew Chem Int Ed 58 (22):7284–7288CrossRef
Tanouchi Y, Lee AJ, Meredith H et al. (2013) Programmed cell death in bacteria and implications for antibiotic therapy. Trends Microbiol 21 (6):265–270PubMedPubMedCentralCrossRef
Thaker MN, Wang W, Spanogiannopoulos P et al. (2013) Identifying producers of antibacterial compounds by screening for antibiotic resistance. Nat Biotechnol 31 (10):922–927PubMedCrossRef
Vetterli S, Zerbe K, Müller M et al. (2018) Thanatin targets the intermembrane protein complex required for lipopolysaccharide transport in Escherichia coli. Sci Adv 4:eaau2634
Vickers CF, Silva APG, Chakraborty A et al. (2018) Structure-based design of MptpB inhibitors that reduce multidrug-resistant Mycobacterium tuberculosis survival and infection burden in vivo. J Med Chem 61 (18):8337–8352PubMedPubMedCentralCrossRef
Vu H, Pedro L, Mak T et al. (2018) Fragment-based screening of a natural product library against 62 potential malaria drug targets employing native mass spectrometry. ACS Infect Dis 4 (4):431–444PubMedPubMedCentralCrossRef
Walsh CT, Wencewicz TA (2014) Prospects for new antibiotics: a molecule-centered perspective. J Antibiotic 67 (1):7–22CrossRef
Wanted: a reward for antibiotic development (2018). Nat Biotechnol 36 (7):555
Wu G-Y, Shi X, Phan H et al. (2020) Efficient self-assembly of heterometallic triangular necklace with strong antibacterial activity. Nat Commun 11 (1):3178PubMedPubMedCentralCrossRef
Yin Z, Wang Y, Whittell LR et al. (2014) DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs. Chem Biol 21 (4):481–487PubMedCrossRef
Zhan J, Jia H, Semchenko EA et al. (2019) Self-derived structure-disrupting peptides targeting methionine aminopeptidase in pathogenic bacteria: a new strategy to generate antimicrobial peptides. FASEB J 33 (2):2095–2104PubMedCrossRef
Zhong W, Koay A, Ngo A et al. (2019) Targeting the bacterial epitranscriptome for antibiotic development: Discovery of novel tRNA-(N1G37)methyltransferase (TrmD) inhibitors. ACS Infect Dis 5 (3):326–335PubMedCrossRef
Zipperer A, Konnerth MC, Laux C et al. (2016) Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535:511–516PubMedCrossRef
Metadaten
Titel
Future Possibilities
verfasst von
John Bremner
Copyright-Jahr
2021
Verlag
Springer Singapore
Buch
Multiple Action-Based Design Approaches to Antibacterials

Print ISBN: 978-981-16-0998-5

Electronic ISBN: 978-981-16-0999-2

Copyright-Jahr: 2021

DOI
https://doi.org/10.1007/978-981-16-0999-2_5